Search clinical trials for: Prostatic MRI

Total 12916 results

European Association of Urology Research Foundation
National Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaborators

Not yet recruiting

Prostate Cancer Awareness and Initiative for Screening in the European Union (PRAISE-U)

Prostate Cancer
University Hospital Padova

Recruiting

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects? (TARGET)

Prostate Cancer Diagnosis

Italy
Chang Gung Memorial Hospital

Recruiting

Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy

Prostate Cancer | Magnetic Resonance Imaging | Randomized Controlled Trial

Taiwan
Adam S. Kibel, MD
National Cancer Institute (NCI)

Recruiting

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer (PRS)

Prostate Cancer | Polygenic Risk Score

United States
Peking University First Hospital

Recruiting

Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis

Prostate Cancer

China
Mayo Clinic

Not yet recruiting

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States
Ivan de Kouchkovsky, MD

Not yet recruiting

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) MRI as a Response Monitoring Tool to Neoadjuvant Abiraterone

Prostate Cancer | High Risk Prostate Carcinoma

United States
Mayo Clinic

Not yet recruiting

Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial (DIVINE)

Recurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate Carcinoma

United States
Mayo Clinic

Recruiting

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States
Peking University First Hospital

Recruiting

Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial

Prostate Cancer

China
Chinese University of Hong Kong

Not yet recruiting

To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence

Prostate Cancer

Hong Kong
Ohio State University Comprehensive Cancer Center
Pfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals America

Not yet recruiting

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Prostate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Mayo Clinic

Not yet recruiting

Evaluating Changes in Quality of Life After Near Margin-less Adaptive Radiation Therapy Compared to Standard Stereotactic Ablative Body Radiotherapy in Localized Prostate Cancer

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Localized Prostate Adenocarcinoma

United States
Brigham and Women's Hospital
National Cancer Institute (NCI); Physical Sciences Inc.

Recruiting

MRI Guided Prostate Biopsy

Suspected Prostate Cancer

United States
Chinese University of Hong Kong

Not yet recruiting

Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

Prostate Cancer

Hong Kong
Roswell Park Cancer Institute

Recruiting

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
IRCCS San Raffaele

Recruiting

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer. (RF2021-1237227)

Clinical Suspicion of Prostate Cancer

Italy
Academisch Medisch Centrum - Universiteit van Amsterdam...
Angiogenesis Analytics

Recruiting

Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision

Prostate Cancer

Netherlands
Imperial College Healthcare NHS Trust
University College London Hospitals; University College, London; University of... and other collaborators

Not yet recruiting

Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance) (IP9-ATLAS)

Prostate Cancer
Molecular Theranostics LLC
Emory University

Not yet recruiting

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

MRI Scan

United States
Fondazione del Piemonte per l'Oncologia
San Luigi Gonzaga Hospital; Epidemiology and Screening Unit - CPO, Turin, Italy

Not yet recruiting

Prostate Cancer Screening: a Pilot Study (ProScreenMRI)

Prostate Cancer

Italy
Fred Hutchinson Cancer Center
PromiCell Therapeutics, Inc.

Not yet recruiting

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
University of Massachusetts, Worcester
Guerbet

Not yet recruiting

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Prostate Cancer

United States
Mayo Clinic

Recruiting

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Biochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate Adenocarcinoma

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection (TRUSVSMPMRI)

PROSTATE CANCER | Prostate Biopsy

China
University of Chicago

Not yet recruiting

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

Prostate Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Recruiting

Prostate Resection After Microwave Ablation (PRAMA)

Prostate Carcinoma

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8

United States
Turku University Hospital
University of Turku

Recruiting

Prostate Metabolism, Cancer Risk and Gut Microbiota (PROMIC)

Prostate Cancer | Prostate Hyperplasia

Finland
Lantheus Medical Imaging

Recruiting

PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer (MIRROR)

Prostate Cancer

United States
European Institute of Oncology
Azienda Ospedaliera Universitaria Integrata Verona; Azienda Socio Sanitaria...

Recruiting

All-in-One Prostate Cancer Staging With MRI (AllinOne_MRI)

Prostate Cancer

Italy
Jonsson Comprehensive Cancer Center
Janssen Scientific Affairs, LLC

Recruiting

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial (HEATWAVE)

Prostate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8

United States
Thomas Jefferson University
GE Healthcare; Amsterdam UMC, location VUmc; Eigen; Eindhoven University of Technology

Not yet recruiting

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Prostate Carcinoma

United States, Netherlands
University Hospital, Brest

Recruiting

Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP) (VARIOP)

Prostate Cancer

France
Menoufia University

Recruiting

Fusion Versus Cognitive MRI Targeted Prostatic Biopsy

Prostatic Cancer

Egypt
Peking University Cancer Hospital & Institute

Recruiting

the Beijing Randomized Study Of Prostate Cancer Screening (BROPCS)

Prostate Cancer

China
University of Washington
Janssen Scientific Affairs, LLC

Recruiting

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Castration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma

United States
First Affiliated Hospital Xi'an Jiaotong University
The First Affiliated Hospital with Nanjing Medical University; The Affiliated... and other collaborators

Recruiting

Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC) (CMNDPC)

Prostate Cancer

China
OHSU Knight Cancer Institute
Oregon Health and Science University; Progenics Pharmaceuticals, Inc.

Not yet recruiting

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Prostate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate Cancer

United States
Turku University Hospital

Recruiting

Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer (NeoADT-TULSA)

Prostate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate Cancer

Finland
University of Zurich

Recruiting

Value of Ultra-fast Prostate MRI in Prostate Cancer

Prostate Cancer

Switzerland
The University of Texas Health Science Center at...
National Cancer Institute (NCI)

Recruiting

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial) (IMAGINED)

Prostate Cancer

United States
National Cancer Institute (NCI)

Recruiting

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

Prostatic Neoplasms | Prostate Specific Antigens | Positive Digital Rectal Examination | Strong Family History of Prostate Cancer

United States
Northwestern University
National Cancer Institute (NCI)

Recruiting

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Prostate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Telix Pharmaceuticals (Innovations) Pty Limited
Grand Pharmaceutical (China) Co., Ltd.

Recruiting

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Prostate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | BCR Prostate Carcinoma

China
National Cancer Institute (NCI)

Recruiting

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

Refractory Prostate Carcinoma

United States
José Joaquín Mira

Recruiting

Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer

Prostate Cancer | Prostate Cancer Diagnosis

Spain
IRCCS San Raffaele

Not yet recruiting

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Prostate Cancer
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Prostate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8

United States
Emory University
National Cancer Institute (NCI); Xencor, Inc.

Recruiting

Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate Carcinoma

United States

Search clinical trials for: Prostatic MRI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations